Mounjaro 12.5 Mg/0.6ml Kwikpen is a once-weekly injectable medication approved by the FDA for managing blood sugar levels in adults with type 2 diabetes. This pre-filled pen offers convenience and helps increase insulin production while reducing sugar output from the liver. While it aids in weight loss, please note it is not FDA approved for this purpose.
Key Features
- Dosage: 12.5 mg per injection
- Form: Pre-filled pen for subcutaneous use
- Storage: Refrigerate between 36°F to 46°F (2°C to 8°C)
Benefits
- Reduces blood sugar levels effectively
- Increases insulin production to manage diabetes
- Aids in weight loss (not FDA approved)
- Provides long-lasting effects for better diabetes control
Side Effects
- Nausea
- Diarrhea
- Decreased appetite
- Vomiting
- Constipation
- Upset stomach
- Serious Side Effects: Potential thyroid tumors and hypoglycemia
Important Information
Mounjaro is a dual GIP/GLP-1 receptor agonist and can be used alone or in combination with other diabetes medications. Consult your healthcare provider for more information.
